RecruitingNot ApplicableNCT06934577

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine- SIGHT 2: A Pragmatic Randomized Trial


Sponsor

University of Michigan

Enrollment

900 participants

Start Date

Dec 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

The Michigan Screening and Intervention for Glaucoma and Eye Health (SIGHT) program is a study focused on detecting glaucoma and other serious eye conditions early in people at high risk — particularly in underserved communities. It combines eye screening with education and referral to specialist care. **You may be eligible if...** - You are an adult, especially aged 40 or older - You have risk factors for glaucoma, such as a family history, African ancestry, or high eye pressure - You have not had a recent comprehensive eye exam - You are willing to participate in screening and follow-up **You may NOT be eligible if...** - You are already under active treatment for glaucoma with a specialist - You have conditions that prevent you from completing eye exams - You are not located near participating screening sites Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStandard optometric examination

Participants will see the optometrist at the Federally Qualified Health Center. The guidelines define usual care as: an in-person comprehensive eye examination with assessment of patient history, visual acuity, pupil examination, ocular motility and alignment, intraocular pressure, and biomicroscopy with additional tests, as appropriate. A glasses prescription will be given to the participant if needed. Participants will complete surveys at baseline before their eye exam and 6 weeks after the eye exam.

OTHERTechnology enhanced eye disease detection protocol

Participants will receive a technology enhanced eye disease detection protocol from ophthalmic technicians that includes measurements of visual function such as visual acuity, refraction, intraocular pressure, pachymetry, external eye and fundus photography, and optical coherence tomography of the macula and retinal nerve fiber layer. The optometrist at the Federally. Qualified Health Center will then use a protocol to grade the testing and identify eye disease. The results of the grading will inform whether the person receives a brief appointment with the optometrist (no disease detected) or an in-depth appointment with the optometrist (disease detected). During the first visit, participants receive care navigation support to purchase low-cost glasses from an on-line retailer. When participants return for the optometrist exam, glasses will be fit. Participants will receive care navigation support to attend any recommended specialty follow-up appointments.


Locations(1)

Hamilton Optometry Clinic

Flint, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06934577


Related Trials